comparison of peppermint and synbiotic in functional abdominal pai
Not Applicable
- Conditions
- abdominal pain.functional diarrhoea- functional disorders of stomach-Dyspepsia - Functional intestinal disorder, unspecified -Flatulence and related conditions -Other and unspecified abdominal pain -Change in bowel habit -Irritable bowel syndrome with diarrhoea - IR14 - R10.
- Registration Number
- IRCT2012110711392N1
- Lead Sponsor
- Medica School , Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
any patient with abdominal pain and age range of 4-18 yrs who seeks medical advice and fulfills Rome III criteria for abdominal pain related functional GI disorders will be entered in this study if be consented. patients will be excluded from study if any alarm sign or red flag such as RUQ or RLQ pain- wt loss or growth impairment- dysphagia-vomiting- anemia- diarrhea (specially nocturnal ) - fever - arthritis - familial history of IBD - or findings suggestive of organic pain be found . any patient or parent whom won,t be consented or won,t follow therapy will be excluded.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Abdominal pain severity. Timepoint: one month after treatment and 3 mo after end of treatment. Method of measurement: asking question from parents and patients based on VAS and NRS scoring.;Abdominal pain frequency. Timepoint: 1 month after treatment and 3 months after end of treatment. Method of measurement: asking question from patient and parents.;Abdominal pain duration. Timepoint: 1 month after treatment and 3 months after end of treatment. Method of measurement: asking question from patient and parents.
- Secondary Outcome Measures
Name Time Method Dyspepsia signs such as fullnes, discomfort, belching and flatulence. Timepoint: one mo after treatment and 3 mo after end of treatment. Method of measurement: asking question from parents and patients.;Defecation abnormality like constipation and diarrhea. Timepoint: 1 months after treatment and 3 months after end of treatment. Method of measurement: asking question from patient and parents.